Your browser doesn't support javascript.
loading
LetsTalkShots: personalized vaccine risk communication.
Salmon, Daniel A; Dudley, Matthew Z; Brewer, Janesse; Shaw, Jana; Schuh, Holly B; Proveaux, Tina M; Jamison, Amelia M; Forr, Amanda; Goryn, Michelle; Breiman, Robert F; Orenstein, Walter A; Kao, Lee-Sien; Josiah Willock, Robina; Cantu, Michelle; Decea, Tori; Mowson, Robin; Tsubata, Kate; Bucci, Lucie Marisa; Lawler, Jaqueline; Watkins, James D; Moore, Jamie W; Fugett, James H; Fugal, Adriele; Tovar, Yazmine; Gay, Marie; Cary, Aleen M; Vann, Iulia; Smith, Lee B; Kan, Lilly; Mankel, Magda; Beekun, Sumayya; Smith, Victoria; Adams, Stephanie D; Harvey, Steven A; Orton, Peter Z.
Afiliação
  • Salmon DA; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Dudley MZ; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Brewer J; Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Shaw J; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Schuh HB; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Proveaux TM; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Jamison AM; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Forr A; Department of Public Health and Preventive Medicine, State University of New York, Upstate Medical University, Syracuse, NY, United States.
  • Goryn M; Department of Pediatrics, State University of New York, Upstate Medical University, Syracuse, NY, United States.
  • Breiman RF; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
  • Orenstein WA; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Kao LS; Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Josiah Willock R; Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Cantu M; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Decea T; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Mowson R; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Tsubata K; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
  • Bucci LM; ieas42.org, New York, NY, United States.
  • Lawler J; Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, United States.
  • Watkins JD; Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
  • Moore JW; Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
  • Fugett JH; Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
  • Fugal A; Bonnemaison, Baltimore, MD, United States.
  • Tovar Y; Bucci-Hepworth Health Services Inc., Pincourt, QC, Canada.
  • Gay M; Orange County Department of Health, Goshen, NY, United States.
  • Cary AM; Williams County Combined Health District, Montpelier, OH, United States.
  • Vann I; Guilford County Division of Public Health, Greensboro, NC, United States.
  • Smith LB; Guilford County Division of Public Health, Greensboro, NC, United States.
  • Kan L; Monongalia County Health Department, Morgantown, WV, United States.
  • Mankel M; Monongalia County Health Department, Morgantown, WV, United States.
  • Beekun S; Orange County Department of Health, Goshen, NY, United States.
  • Smith V; Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
  • Adams SD; Utah County Health Department, Provo, UT, United States.
  • Harvey SA; Guilford County Division of Public Health, Greensboro, NC, United States.
  • Orton PZ; Department of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
Front Public Health ; 11: 1195751, 2023.
Article em En | MEDLINE | ID: mdl-37457264
ABSTRACT

Introduction:

Vaccine hesitancy is a global health threat undermining control of many vaccine-preventable diseases. Patient-level education has largely been ineffective in reducing vaccine concerns and increasing vaccine uptake. We built and evaluated a personalized vaccine risk communication website called LetsTalkShots in English, Spanish and French (Canadian) for vaccines across the lifespan. LetsTalkShots tailors lived experiences, credible sources and informational animations to disseminate the right message from the right messenger to the right person, applying a broad range of behavioral theories.

Methods:

We used mixed-methods research to test our animation and some aspects of credible sources and personal narratives. We conducted 67 discussion groups (n = 325 persons), stratified by race/ethnicity (African American, Hispanic, and White people) and population (e.g., parents, pregnant women, adolescents, younger adults, and older adults). Using a large Ipsos survey among English-speaking respondents (n = 2,272), we tested animations aligned with vaccine concerns and specific to population (e.g., parents of children, parents of adolescents, younger adults, older adults).

Results:

Discussion groups provided robust feedback specific to each animation as well as areas for improvements across animations. Most respondents indicated that the information presented was interesting (85.5%), clear (96.0%), helpful (87.0%), and trustworthy (82.2%).

Discussion:

Tailored vaccine risk communication can assist decision makers as they consider vaccination for themselves, their families, and their communities. LetsTalkShots presents a model for personalized communication in other areas of medicine and public health.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Vacinação / Comunicação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Equity_inequality Limite: Adolescent / Adult / Aged / Child / Female / Humans / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: Front Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Vacinação / Comunicação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Equity_inequality Limite: Adolescent / Adult / Aged / Child / Female / Humans / Pregnancy País/Região como assunto: America do norte Idioma: En Revista: Front Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos